CTS CORP — Form 8-K
Filed October 27, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 58/100
What the filing says
CTS Corporation reported Q3 2026 revenue of $149.6M (+5% YoY), net income of $17.8M (11.9% margin), and adjusted diluted EPS of $0.77 (+$0.17 YoY). The company raised full-year 2026 guidance: revenue from $565–585M to $580–590M; adjusted diluted EPS from $2.55–$2.70 to $2.78–$2.88. CTS acquired Millar (expected ~$30M annual revenue, closing 2H 2027), a medical pressure-sensing company, to advance diversification into medical/life sciences markets. Diversified end-market revenue grew 7% YoY to 60% of sales; transportation revenue grew 2%. Adjusted gross margin expanded 330 bps to 42.2%; adjusted EBITDA margin rose 90 bps to 24.7%. Free cash flow YTD Q3 was $82.3M.
Why this rating
Guidance raise (~3% revenue, ~9% EPS upside), Millar tuck-in advancing stated diversification strategy, and margin expansion are real but modest relative to $1.2B market cap. Not transformational—Millar is ~2.5% of 2026 guidance sales.
See more from October 27, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.